BioTelemetry, Inc. Reports Third Quarter 2018 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
BioTelemetry (BEAT) Tops Q3 EPS by 21c; Raises Outlook
October 30, 2018 4:08 PM EDTBioTelemetry (NASDAQ: BEAT) reported Q3 EPS of $0.53, $0.21 better than the analyst estimate of $0.32. Revenue for the quarter came in at $100 million versus the consensus estimate of $97.92 million.
GUIDANCE:
BioTelemetry sees FY2018 revenue of $397-400 million, versus the consensus of $394.2... More
